Antifungal Agents. Part I. Amphotericin B Preparations and Flucytosine
- 1 December 1998
- journal article
- review article
- Published by Elsevier in Mayo Clinic Proceedings
- Vol. 73 (12) , 1205-1225
- https://doi.org/10.4065/73.12.1205
Abstract
No abstract availableKeywords
This publication has 206 references indexed in Scilit:
- Disseminated Zygomycosis in a Neutropenic Patient: Successful Treatment with Amphotericin B Lipid Complex and Granulocyte Colony-Stimulating FactorClinical Infectious Diseases, 1997
- Cytosine arabinoside and amphotericin B‐induced parkinsonismAnnals of Neurology, 1996
- Aerosol amphotericin B inhalations for prevention of invasive pulmonary aspergillosis in neutropenic cancer patientsAnnals of Hematology, 1995
- Successful treatment of catheter-related fusarial infection in immunocompromised childrenEuropean Journal of Clinical Microbiology & Infectious Diseases, 1995
- Treatment of deep mycoses with liposomal amphotericin BEuropean Journal of Clinical Microbiology & Infectious Diseases, 1994
- Treatment of Cryptococcal Meningitis with Combination Amphotericin B and Flucytosine for Four as Compared with Six WeeksNew England Journal of Medicine, 1987
- Amphotericin-b nephrotoxicity in humans decreased by sodium supplements with coadministration of ticarcillin or intravenous salineJournal of Molecular Medicine, 1987
- Acute Pulmonary Decompensation Due to Amphotericin B in the Absence of Granulocyte TransfusionsNew England Journal of Medicine, 1986
- Lethal Pulmonary Reactions Associated with the Combined Use of Amphotericin B and Leukocyte TransfusionsNew England Journal of Medicine, 1981
- A Comparison of Amphotericin B Alone and Combined with Flucytosine in the Treatment of Cryptoccal MeningitisNew England Journal of Medicine, 1979